HK1213470A1 - 含有四氫吡喃基氨基環戊基羰基四氫吡啶並吡啶衍生物作爲有效成分的眼後段疾病的預防或治療劑 - Google Patents

含有四氫吡喃基氨基環戊基羰基四氫吡啶並吡啶衍生物作爲有效成分的眼後段疾病的預防或治療劑

Info

Publication number
HK1213470A1
HK1213470A1 HK16101254.1A HK16101254A HK1213470A1 HK 1213470 A1 HK1213470 A1 HK 1213470A1 HK 16101254 A HK16101254 A HK 16101254A HK 1213470 A1 HK1213470 A1 HK 1213470A1
Authority
HK
Hong Kong
Prior art keywords
tetrahydropyridopyridine
cyclopentylcarbonyl
eye
derivative
preventing
Prior art date
Application number
HK16101254.1A
Other languages
English (en)
Inventor
篤史 吉田
沙繪 赤尾
信次 米田
高明 岡部
友美 小原
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of HK1213470A1 publication Critical patent/HK1213470A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Dermatology (AREA)
HK16101254.1A 2013-02-28 2016-02-03 含有四氫吡喃基氨基環戊基羰基四氫吡啶並吡啶衍生物作爲有效成分的眼後段疾病的預防或治療劑 HK1213470A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013038703 2013-02-28
PCT/JP2014/054852 WO2014133072A1 (ja) 2013-02-28 2014-02-27 テトラヒドロピラニルアミノシクロペンチルカルボニルテトラヒドロピリドピリジン誘導体を有効成分として含有する後眼部疾患の予防または治療剤

Publications (1)

Publication Number Publication Date
HK1213470A1 true HK1213470A1 (zh) 2016-07-08

Family

ID=51428331

Family Applications (2)

Application Number Title Priority Date Filing Date
HK16101254.1A HK1213470A1 (zh) 2013-02-28 2016-02-03 含有四氫吡喃基氨基環戊基羰基四氫吡啶並吡啶衍生物作爲有效成分的眼後段疾病的預防或治療劑
HK16104219.9A HK1216233A1 (zh) 2013-02-28 2016-04-13 含有四氫吡喃基氨基環戊基羰基四氫吡啶並吡啶衍生物作為有效成分的眼後段疾病的預防或治療劑

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK16104219.9A HK1216233A1 (zh) 2013-02-28 2016-04-13 含有四氫吡喃基氨基環戊基羰基四氫吡啶並吡啶衍生物作為有效成分的眼後段疾病的預防或治療劑

Country Status (9)

Country Link
US (1) US9579309B2 (zh)
EP (1) EP2962691A4 (zh)
JP (1) JP2014193854A (zh)
KR (1) KR20150119861A (zh)
CN (1) CN104981243A (zh)
CA (1) CA2902785A1 (zh)
HK (2) HK1213470A1 (zh)
TW (1) TW201442706A (zh)
WO (1) WO2014133072A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2017000580A (es) * 2014-07-17 2017-09-01 Santen Pharmaceutical Co Ltd Agente profilactico o terapeutico para enfermedades del segmento posterior del ojo.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1501507T1 (sl) 2002-04-29 2008-12-31 Merck & Co Inc Tetrahidropiranil ciklopentil tetrahidropiridopiridin modulatorji s kemokinsko receptorsko aktivnostjo
KR20060101476A (ko) 2003-10-27 2006-09-25 머크 앤드 캄파니 인코포레이티드 Ｃｃｒ-2 길항제 염
US8168829B2 (en) 2007-10-26 2012-05-01 Janssen Pharmaceutica N.V. Synthesis of quaternary salt compounds
WO2012094703A1 (en) 2011-01-11 2012-07-19 Dimerix Bioscience Pty Ltd Combination therapy

Also Published As

Publication number Publication date
EP2962691A4 (en) 2016-08-31
TW201442706A (zh) 2014-11-16
US9579309B2 (en) 2017-02-28
JP2014193854A (ja) 2014-10-09
US20160008333A1 (en) 2016-01-14
WO2014133072A1 (ja) 2014-09-04
HK1216233A1 (zh) 2016-10-28
EP2962691A1 (en) 2016-01-06
CN104981243A (zh) 2015-10-14
KR20150119861A (ko) 2015-10-26
CA2902785A1 (en) 2014-09-04

Similar Documents

Publication Publication Date Title
IL267997A (en) Preparations, formulations and methods for treating eye diseases
HK1258588A1 (zh) 用於治療眼科疾病的化合物和製劑
PH12016500582A1 (en) Heterocyclic compounds and uses thereof
HK1219943A1 (zh) 用於治療眼科疾病和障害的取代 -苯基丙胺衍生物
HUE061618T2 (hu) Vegyület szemrendellenességek kezelésére
HK1220324A1 (zh) 用於治療血管緊張素相關疾病的方法、化合物和組合物
PL2968218T3 (pl) Skojarzenie do leczenia choroby parkinsona
EP2928424A4 (en) SYSTEMS AND METHOD FOR MOISTENING EYES DURING EYE OPERATION
HK1222331A1 (zh) 修飾的繆勒抑制物質 蛋白及其用於疾病治療的用途
HK1216236A1 (zh) 給藥於眼後段的眼用製劑
EP3060259A4 (en) Methods of treating or preventing vascular diseases of the retina
IL242355B (en) Cannabidiol for the prevention and treatment of graft-versus-host disease
IL270159B (en) Preparations containing nanometer particles for the administration of drugs for the treatment of eye diseases
SI3049100T1 (sl) Modificirani faktorji rasti fibroblasta-1 za zdravljenje očesnih motenj
EP2948219A4 (en) TARGETING THE STEROIDOGENIC PATH TO TREAT AND / OR PREVENT ALLERGIC DISEASES
EP2964750A4 (en) METHOD AND COMPOSITIONS FOR TREATING AND / OR PREVENTING TYPE-1 DIABETES
EP2910247A4 (en) COMPOSITIONS FOR PREVENTING OR TREATING ALLERGIC SKIN DISORDERS CONTAINING GPCR19 AGENTS AS ACTIVE INGREDIENTS
HK1216233A1 (zh) 含有四氫吡喃基氨基環戊基羰基四氫吡啶並吡啶衍生物作為有效成分的眼後段疾病的預防或治療劑
PL3515409T3 (pl) Kompleks i kompozycje do leczenia chorób okulistycznych i dermatologicznych
PL3689341T3 (pl) Gabapentyna okulistyczna do leczenia deepitelializacji rogówki
HK1220144A1 (zh) -叔丁基-苄基 -氯- -氯- -乙基-苯基 -乙基 -氟- -三氟甲基-苯甲酰胺用於治療眼疾病的用途
GEP20207145B (en) Combination of trazodone and gabapentin for the treatmen
EP3085369A4 (en) Therapeutic and/or preventive agent comprising 1-indansulfamide derivative for pain
EP3003341A4 (en) Compositions and methods for treatment of retinal degenerative diseases